{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:45:18Z","timestamp":1777005918794,"version":"3.51.4"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,11,15]]},"DOI":"10.2169\/internalmedicine.1561-23","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T22:12:55Z","timestamp":1680819175000},"page":"3413-3417","source":"Crossref","is-referenced-by-count":7,"title":["Atypical Cogan's Syndrome with Large-vessel Vasculitis Successfully Treated with Tocilizumab"],"prefix":"10.2169","volume":"62","author":[{"given":"Misako","family":"Higashida-Konishi","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, National Hospital Organization Tokyo Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, National Hospital Organization Tokyo Medical Center, Japan"},{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Tabata","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, National Hospital Organization Tokyo Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Hama","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, National Hospital Organization Tokyo Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiro","family":"Oshige","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, National Hospital Organization Tokyo Medical Center, Japan"},{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Izumi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, National Hospital Organization Tokyo Medical Center, Japan"},{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisaji","family":"Oshima","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, National Hospital Organization Tokyo Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Okano","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, National Hospital Organization Tokyo Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Cogan D. Syndrome of non-syphilitic interstitial keratitis and vestibulo-auditory symptoms. Arch Ophthalmol 33: 144-149, 1945.","DOI":"10.1001\/archopht.1945.00890140064007"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Nadeau SE. Neurologic manifestations of connective tissue disease. Neurol Clin 20: 151-178, 2002.","DOI":"10.1016\/S0733-8619(03)00057-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Stone JH, Tuckwell K, Dimonaco S, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med 377: 317-328, 2017.","DOI":"10.1056\/NEJMoa1613849"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nakaoka Y, Isobe M, Takei S, et al. Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study). Ann Rheum Dis 77: 348-354, 2018.","DOI":"10.1136\/annrheumdis-2017-211878"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Higashida-Konishi M, Akiyama M, Shimada T, et al. Giant cell arteritis successfully treated with subcutaneous tocilizumab monotherapy. Rheumatol Int 43: 545-549, 2023.","DOI":"10.1007\/s00296-022-05217-x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Haynes BF, Kaiser-Kupfer MI, Mason P, Fauci AS. Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine (Baltimore) 59: 426-441, 1980.","DOI":"10.1097\/00005792-198011000-00003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Grasland A, Pouchot J, Hachulla E, et al. Typical and atypical Cogan's syndrome: 32 cases and review of the literature. Rheumatology (Oxford) 43: 1007-1015, 2004.","DOI":"10.1093\/rheumatology\/keh228"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gluth MB, Baratz KH, Matteson EL, Driscoll CLW. Cogan syndrome: a retrospective review of 60 patients throughout a half century. Mayo Clin Proc 81: 483-488, 2006.","DOI":"10.4065\/81.4.483"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Fricker M, Baumann A, Wermelinger F, Villiger PM, Helbling A. A novel therapeutic option in Cogan diseases? TNF-\u03b1 blockers. Rheumatol Int 27: 493-495, 2007.","DOI":"10.1007\/s00296-006-0252-y"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Utz JP, Jinnur PK, Yi ES, Ryu JH, Midthun DE, Davis JM 3rd. Acute bilateral pulmonary opacities associated with use of tocilizumab. J Clin Rheumatol 21: 382-385, 2015.","DOI":"10.1097\/RHU.0000000000000304"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kougkas N, Bertsias G, Stratoudaki R, Avgoustidis N. Successful treatment of Cogan's syndrome with tocilizumab. Scand J Rheumatol 50: 330-331, 2021.","DOI":"10.1080\/03009742.2020.1818822"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Shibuya M, Fujio K, Morita K, Harada H, Kanda H, Yamamoto K. Successful treatment with tocilizumab in a case of Cogan's syndrome complicated with aortitis. Mod Rheumatol 23: 577-581, 2013.","DOI":"10.3109\/s10165-012-0691-0"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hidalgo TA, Gonz\u00e1lez AJG, Casta\u00f1eda S, Tomero EG, \u00c1lvarez JLP. Cogan syndrome: descriptive analysis and clinical experience of 7 cases diagnosed and treated in two third level hospitals. Reumatol Clin (Engl Ed) 17: 318-321, 2021.","DOI":"10.1016\/j.reumae.2019.11.003"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hara K, Umeda M, Segawa K, et al. Atypical Cogan's syndrome mimicking giant cell arteritis successfully treated with early administration of tocilizumab. Intern Med 61: 1265-1270, 2022.","DOI":"10.2169\/internalmedicine.7674-21"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Koster MJ, Matteson EL, Warrington KJ. Recent advances in the clinical management of giant cell arteritis and Takayasu arteritis. Curr Opin Rheumatol 28: 211-217, 2016.","DOI":"10.1097\/BOR.0000000000000265"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Su G, Zhong Z, Zhou Q, et al. Identification of novel risk loci for Beh\u00e7et's disease-related uveitis in a Chinese population in a genome-wide association study. Arthritis Rheumatol 74: 671-681, 2022.","DOI":"10.1002\/art.41998"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Takamura C, Ohhigashi H, Ebana Y, Isobe M. New human leukocyte antigen risk allele in Japanese patients with Takayasu arteritis. Circ J 76: 1697-1702, 2012.","DOI":"10.1253\/circj.CJ-12-0089"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Tseng JF, Cambria RP, Aretz HT, Brewster DC. Thoracoabdominal aortic aneurysm in Cogan's syndrome. J Vasc Surg 30: 565-568, 1999.","DOI":"10.1016\/S0741-5214(99)70086-8"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Kawamura S, Sakamoto T, Kashio A, et al. Cochlear implantation in a patient with atypical Cogan's syndrome complicated with hypertrophic cranial pachymeningitis. Auris Nasus Larynx 37: 737-741, 2010.","DOI":"10.1016\/j.anl.2010.04.005"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Durtette C, Hachulla E, Resche-Rigon M, et al. Cogan syndrome: characteristics, outcome and treatment in a French nationwide retrospective study and literature review. Autoimmun Rev 16: 1219-1223, 2017.","DOI":"10.1016\/j.autrev.2017.10.005"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/22\/62_1561-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:29:49Z","timestamp":1715574589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/22\/62_1561-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":20,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1561-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"article-number":"1561-23"}}